global medical technology market is expected to be $600 billion by 2025
indicating a manufacturing base of $200 billion by the time. India will capture
about 10% of that share by 2025 in line with China's share today, said Dr. Harsh
Vardhan, Minister for Science & Technology, Government of India.
The Union minister was speaking at a press conference organized by the Department
of Biotechnology (DBT), Ministry of Science and Technology at the CSIR Science
Centre, New Delhi on 12th January 2016. Dr. Vijay Raghavan, Secretary, DBT, and
other senior officials were also present at the event.
‘Medical technology industry in India is the fourth largest in Asia. Now it aims to become a global superpower by capturing about 10% of the global market share of medical technology by 2025.’
department also showcased several low-cost medical innovations - some of them
developed in association with startups - including home kits for measuring
blood glucose levels
and real-time diagnosis of malaria
Other points Dr. Vardhan shared are as
- At present,
medical technology industry in India is the fourth largest in Asia. India
was assessed at US$6.3 billion in 2013.
- Growing at 10-12%
per year until 2025 indicates an overall healthcare spend of US$250-350
penetration levels of 8% indicate a domestic market of $20-25 billion;
- Indian device
market consists of medical instruments, syringes, needles, catheters, scanning devices and bandages, and orthopedic and ophthalmic devices.
'Make in India' initiative
led by Prime Minister Narendra Modi aims to
propel the country to exceptional heights. Innovation in medical technology and
health care is especially of great significance and can accelerate the
country's economic and social growth.
DBT, since its inception, has spearheaded biomedical research in the country
and continued to do so. Recognizing the
need for Medical Technology Innovation, the DBT is promoting this sector by
supporting various initiatives across the country that have significantly
resulted in affordable products of societal and public health relevance.
sector has seen a large number of successful scientists, talented entrepreneurs
and young startups building their own enterprises. The complete value chain
from product discovery to commercialization has been expedited and today we
have around 40 medical devices and diagnostics some of which have received U.S.
Food and Drug Administration clearances.
a mobile app for information related to drugs
sold in India, Bioscoop, a safer and easy method to perform a percutaneous liver biopsy
Uthishtami, a device to help the elderly stand up independently from a sitting
position are among the 40 novel medical devices and diagnostics launched by the
program is one of the examples of inclusive medical technology innovation. This
is based on a novel approach to an end-to-end process that starts with idea
formation through clinical immersion up to commercialization by a team
comprising an engineer, physician, product designer, and an entrepreneur. The
objective of this drive is to train next generation of medical technology
innovators who will, in turn, focus on
invention and early-stage development of low cost new medical technologies for the Indian population. The aim is to develop simple, indigenous, rapid,
low-cost medical devices and implants by applying four components i.e. availability, affordability, accessibility, and appropriateness.
this program, several indigenous medical devices have been developed to address
unmet medical demands of India. As a result, more than 100 innovators have been
trained. Several national and international patents have been filed. About 30
prototypes have been developed. Nine start-up companies have been established
by the Fellows and interns of this program. As many as 13 technologies have
been licensed, and nine start-up companies launched. International
collaborations have been established with Tottori University, Japan; QUT,
Australia; and Stanford University, USA.
Healthcare Technology Innovation Center
(HTIC) established at IIT-Madras is delivering technologies and innovations
that are reaching the field through industry partnerships and government,
producing advantages to lives and our society. Biotechnology Industry Research
Assistance Council (BIRAC) is a Public Sector Undertaking set-up by the
Department. BIRAC has supported nearly 300 Start-up's and small and medium
enterprises (SME's) and 150 young entrepreneurs for innovation, and product
development. The biotech startup scenario in the country was transformed by
BIRAC's flagship schemes.
young entrepreneurs have been supported for Med-Tech Innovation, and more than
10 Med-Tech Products supported by BIRAC have been successfully marketed.